Andreas Kjær

Andreas Kjær

Professor


  1. 2022
  2. Published

    First-In-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability

    Clausen, Malene Martini, Carlsen, E. A., Christensen, C., Madsen, J., Brandt-Larsen, M., Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K., Kroman, Niels Thorndahl, Knigge, Ulrich & Kjær, Andreas, 2022, In: Diagnostics. 12, 4, 15 p., 851.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Development of18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging

    García-Vázquez, R., Jørgensen, Jesper Tranekjær, Bratteby, K. E., Shalgunov, Vladimir, Hvass, Lars, Herth, Matthias Manfred, Kjær, Andreas & Battisti, Umberto Maria, 2022, In: Pharmaceuticals. 15, 2, 28 p., 245.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms

    Holmager, P., Langer, Seppo W., Kjær, Andreas, Ringholm, L., Garbyal, Rajendra Singh, Pommergaard, Hans-Christian L, Hansen, C. P., Federspiel, B., Andreassen, Mikkel & Knigge, Ulrich, 2022, In: Current Treatment Options in Oncology. 23, 6, p. 806-817 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published
  7. Published

    Feasibility of positron range correction in 82-Rubidium cardiac PET/CT

    Jensen, Malte Engmann Kjeldskov, Bentsen, Simon, Clemmensen, Andreas Høeg, Jensen, Jacob Kildevang, Madsen, Johanne Straarup, Rossing, J., Laier, A., Hasbak, P., Kjær, Andreas & Ripa, Rasmus Sejersten, 2022, In: EJNMMI Physics. 9, 1, 18 p., 51.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published
  9. Published

    Image-derived and physiological markers to predict adequate adenosine-induced hyperemic response in Rubidium-82 myocardial perfusion imaging

    Lassen, M. L., Wissenberg, M., Byrne, C., Sheykhzade, Majid, Hurry, P. K., Schmedes, A. V., Kjær, Andreas & Hasbak, P., 2022, In: Journal of Nuclear Cardiology. 29, p. 3207–3217

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Optimization of the left ventricle ejection fraction estimate obtained during cardiac adenosine stress 82Rubidium-PET scanning: impact of different reconstruction protocols

    Lassen, M. L., Wissenberg, M., Byrne, C., Kjær, Andreas & Hasbak, P., 2022, In: Journal of Nuclear Cardiology. 29, p. 3369–3378

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Sex differences and caffeine impact in adenosine-induced hyperemia

    Lassen, M. L., Byrne, C., Sheykhzade, Majid, Wissenberg, M., Hurry, P. K., Schmedes, A. V., Kjær, Andreas & Hasbak, P., 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 3, p. 431-437 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402